Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor.
Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.
Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.
Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools.
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.
Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes.
Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study.
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.
Grb2 Is Important for T Cell Development, Th Cell Differentiation, and Induction of Experimental Autoimmune Encephalomyelitis.
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
A Two Sample Distribution-Free Test for Functional Data with Application to a Diffusion Tensor Imaging Study of Multiple Sclerosis.
Alemtuzumab for multiple sclerosis.
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
Palmoplantar Keratoderma and Charcot-Marie-Tooth: combination of two independent genetic diseases? Identification of two point mutations in CMT2 and PPK genes by whole exome sequencing.
Identification of genetic determinants of the sexual dimorphism in CNS autoimmunity.
[Smoking and multiple sclerosis].
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
The crystal structure of an integral membrane fatty acid α-hydroxylase.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Measurement characteristics and clinical utility of the Brief Pain Inventory-Short Form for individuals with multiple sclerosis.
Deep morphea induced by interferon-β1b injection.
A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple Sclerosis.
Multiple sclerosis in Saudi Arabia: Anxiety, depression and suicidality.
NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis.

Pages